Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)

Published:2024-01 Issue:1 Volume:25 Page:e18-e28
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Siva Shankar,Louie Alexander V,Kotecha Rupesh,Barber Melissa N,Ali Muhammad,Zhang Zhenwei,Guckenberger Matthias,Kim Mi-Sook,Scorsetti Marta,Tree Alison C,Slotman Ben J,Sahgal Arjun,Lo Simon S

Publisher

Elsevier BV

Reference54 articles.

1. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma;Van Poppel;Eur Urol,2011

2. Renal mass and localized renal cancer: AUA guideline;Campbell;J Urol,2017

3. Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline;Finelli;J Clin Oncol,2017

4. Kidney cancer, version 3·2022, NCCN clinical practice guidelines in oncology;Motzer;J Natl Compr Canc Netw,2022

5. Ablative therapies for localized primary renal Cell Carcinoma;Ali;Soc Int Urol J,2022

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable Local Control With Preserved Renal Function for Stereotactic Body Radiotherapy in Cryoablation-Refractory Clear Cell Renal Carcinoma;Cureus;2024-09-07

2. Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer;BJU International;2024-08-26

3. Prognostic assessment of patients with bone metastatic renal cell cancer treated with palliative radiotherapy;Oncology Letters;2024-08-07

4. Re: Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Non-randomised Phase 2 Trial;European Urology;2024-08

5. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC);Cancers;2024-07-27